We are a team of specialists on a joint mission

As a Danish commercial foundation, the LEO Foundation is fully independent of outside interests and has no owners or personal beneficiaries.

The LEO Foundation has established a transparent governance model with clearly defined roles and responsibilities.

The Foundation is governed by the Board of Trustees.

The daily management is carried out by the Foundation’s CEO, assisted by a small management team.

Board of Trustees

The LEO Foundation Board of Trustees consists of 11 members. Seven members are appointed in accordance with the Foundation’s charter, while four members are elected by LEO Pharma employees in accordance with applicable law.

The composition of the Board reflects the qualifications and skills necessary for the LEO Foundation to fulfil the objectives specified in its charter.

The Board of Trustees strive to ensure that, by 2020, at least 40% of its members elected according to the charter are female and, similarly, that at least 40% of its members elected according to the charter are male.

The members of the LEO Foundation’s Board of Trustees also make up the Board of Directors of LEO Holding A/S.

Work of the Boards

Matters related to overall strategies and the Foundation’s grant activities are handled by the Board of the LEO Foundation, while matters related to investments and our engaged ownership of LEO Pharma are handled in the Board of LEO Holding.

Both boards meet at least four times a year and, in addition, hold an annual seminar to discuss and review strategies.

Remuneration

Each member of the Board as well as the CEO receives a fixed annual fee at a reasonable and customary level and is not entitled to any bonus or other type of incentive payments. Please find detailed overview of remuneration in our annual report (p 35).

Lars Olsen

Chairman of the Board

MD, MBA

Elected to the Board of Trustees: 2015 (re-elected 2019, end of term 2021)

Born: 1965 (M)

Background

  • Executive Vice President, Global Sales & Marketing, LEO Pharma
  • Executive Vice President, Research & Development, LEO Pharma

Additional positions held

  • LEO Holding A/S, Chairman
  • LEO Holding A/S, Investment Committee, Member

Appointed by authorities: No

Considered independent: No

Eivind Kolding

Vice chairman of the Board

MA Law, admitted to the Danish High Court

Elected to the Board of Trustees: 2017 (re-elected 2019, end of term 2021)

Born: 1959 (M)

Background

  • CEO, Novo A/S
  • CEO, Danske Bank A/S
  • Group CFO, later CEO, A.P.Møller-Mærsk A/S
  • Lawyer, Bornstein & Grønborg

Additional positions held

  • LEO Holding A/S, Vice chairman
  • LEO Holding A/S, Investment Committee, Member
  • Danish Ship Finance, Chairman
  • CASA Group, Chairman
  • NNIT, Board member
  • Axcelfuture, Advisory board member
  • Alto Fund Manager AB, Board member
  • Kunstforeningen Gammel Strand, Chairman
  • BiQ ApS, Board member
  • NTG Nordic Transport Group A/S, Chairman

Appointed by authorities: No

Considered independent: Yes

Allan Dahl

Board member, employee-elected

MSc Chemistry, PhD

Elected to the Board of Trustees: 2015 (re-elected 2018, end of term 2022)

Born: 1967 (M)

Background

  • Development Chemist, PharmaZell Denmark A/S
  • Development Chemist, GEA Pharmaceutical A/S
  • Development Chemist, H. Lundbeck A/S
  • Research and Development Chemist, Niels Clauson-Kaas A/S

Additional positions

  • LEO Holding A/S, Board member

Appointed by authorities: No

Considered independent: No

Anja Boisen

Board member

Professor at DTU Health Technology, Director of the IDUN Centre of Excellence

Elected to the Board of Trustees: 2019 (end of term 2021)

Born: 1967 (F)

Background

  • Director, VKR Centre of Excellence ‘NAMEC’
  • Development Engineer, Cantion A/S
  • Associate Professor, DTU

Additional positions held

  • LEO Holding A/S, Board member
  • LEO Foundation, Grant Committee, Member
  • DTU Health Tech, Head of Section
  • Innovation Fund Denmark, Vice Chair of the Board
  • The Royal Danish Academy of Sciences and Letters, Member
  • Villum Foundation, Board member
  • Lightnovo ApS, Board member

Appointed by authorities: No

Considered independent: Yes

Cristina Lage

Board member

MSc Economics

Elected to the Board of Trustees: 2016 (re-elected 2019, end of term 2021)

Born: 1954 (F)

Background

  • CEO, Unipension A/S
  • CEO, Nordea Invest A/S
  • CEO, Nordea Liv og Pension A/S
  • Secretary General, Social Liberal Party
  • CEO, TV2/ Danmark A/S
  • CEO, Louisiana Museum of modern Art
  • CFO, ISS Scandinavia A/S

Additional positions held

  • LEO Holding A/S, Board member
  • LEO Pharma A/S, Board member
  • LEO Holding A/S, Investment Committee, Chairman
  • Arbejdsmiljørådet, Chairman
  • Topdanmark A/S, Board member
  • Topdanmark A/S, member of Audit Committee
  • Det Obelske Familiefond, Board member
  • C.L. Davids Fond, Board member

Appointed by authorities: No

Considered independent: Yes

Jannie Kogsbøll

Board member, employee-elected

Process Assistant

Elected to the Board of Trustees: 1998 (re-elected 2018, end of term 2022)

Born: 1962 (F)

Background

  • F Group A/S (Fona)

Additional positions held

  • LEO Holding A/S, Board member
  • LEO Pharma A/S, Board member
  • Employee Union, Treasurer

Appointed by authorities: No

Considered independent: No

Karin Jexner Hamberg

Board member

Senior Vice President, Medical & Regulatory Science, H. Lundbeck A/S, Denmark, MD

Elected to the Board of Trustees: 2019 (end of term 2021)

Born: 1961 (F)

Background

  • Vice President, Medical Affairs & Clinical Development Centers, H. Lundbeck A/S, Denmark
  • Vice President, Clinical Study Execution, H. Lundbeck A/S, Denmark
  • Executive Vice President, CMO, Lifecycle Pharma (now Veloxis), Hørsholm, Denmark & New York City, USA
  • Vice President, Development, LEO Pharma, Denmark
  • Director, R&D Project Management, LEO Pharma, Denmark

Additional positions held

  • LEO Holding A/S, Board member
  • LEO Foundation, Grant Committee, Member
  • Innovative Medicines Strategy Group (InnoMeds), EU Innovative Medicines Initiative (IMI), Member
  • Regulatory Strategy Committee, EFPIA, Company Representative
  • ECNP (European College of Neuropharmacology)
  • ISCTM (International Society for CNS Clinical Trials)

Appointed by authorities: No

Considered independent: Yes

Lars Green

Board member

CFO & Executive Vice President, Finance, IT & Legal, Novozymes A/S

Elected to the Board of Trustees: 2020 (end of term 2021)

Born: 1967 (M)

Background

  • Novozymes A/S, Chairman of the Audit Committee
  • Executive Vice President, Business Services & Compliance, Novo Nordisk
  • Senior Vice President, Finance and Operations, Novo Nordisk Inc., based in NJ, USA
  • Senior Vice President, Corporate Finance, Novo Nordisk group
  • Vice President, Corporate Finance, Novo Nordisk group
  • Director of Finance & IT, Novo Nordisk Pharma Ltd., based in Tokyo, Japan

Additional positions held

  • LEO Holding A/S, Board member

Appointed by authorities: No

Considered independent: Yes

Lars Kjøller

Board member, employee-elected

MSc (Library & Information Science), PhD (Molecular Biology)

Elected to the Board of Trustees: 2017 (re-elected 2018, end of term 2022)

Born: 1967 (M)

Background

  • Senior Researcher, Copenhagen University Hospital (Rigshospitalet)
  • Post-doc researcher, University College London
  • Assistant Professor, Aarhus University

Additional positions

  • LEO Holding A/S, Board member

Appointed by authorities: No

Considered independent: No

Lotte Hjortshøj Larsen

Board member, employee-elected

Diploma Graduate

Elected to the Board of Trustees: 2018 (end of term 2022)

Born: 1971 (F)

Background

  • Personal Assistant, LEO Pharma
  • Head of HR Administration, LEO Pharma
  • HR Coordinator, LEO Pharma
  • Project Manager, LEO Pharma

Additional positions held

  • LEO Holding A/S, Board member

Appointed by authorities: No

Considered independent: No

Peter Schwarz

Board member

Professor, MD, DMSci, Department of Endocrinology, Rigshospitalet & Institute of Clinical Medicine, Copenhagen University

Elected to the Board of Trustees: 2017 (re-elected 2019, end of term 2021)

Born: 1959 (M)

Background

  • Research Fellow, Harvard Medical School
  • Head of Department, Hvidovre Hospital
  • Professor, Glostrup Hospital

Additional positions held

  • LEO Holding A/S, Board member
  • LEO Foundation Grant Committee, Chairman

Appointed by authorities: No

Considered independent: Yes

Comittees

Two permanent board committees have been set up: a Grant Committee (as part of the LEO Foundation) and an Investment Committee (as part of LEO Holding A/S). Both meet at regular intervals.

In addition, ad hoc committees are established when deemed relevant to handle specific matters.

Grant Committee

The Grant Committee supervises all grant and award activities and advises the Board on relevant matters, including grant strategies and policies. The Grant Committee also ensures that all grant and award applications undergo relevant assessment to ensure alignment with the Foundation’s objectives for its philanthropic activities.

This includes evaluation of applications by scientific evaluation committees with external members who, among other things, assess the scientific topic being researched, the qualifications of the applicant and the academic standard of the host institution. All grants and awards are decided by the Board of Trustees.

Committee member Titles

Peter Schwarz

Chairman of the Grant Committee

Anja Boisen

Member of the Grant Committee

Karin Jexner Hamberg

Member of the Grant Committee

Investment Committee

The Investment Committee advises the Board on matters relating to investments and asset management. It prepares and recommends investment strategies and policies to the Board and ensures their implementation in cooperation with the Executive Management.

The Committee also monitors and reviews relevant internal controls, risk management and governance models.

Committee member Titles

Cristina Lage

Chairman of the Investment Committee

Eivind Kolding

Member of the Investment Committee

Lars Olsen

Member of the Investment Committee

Our team

The LEO Foundation organisation is made up by a small and dedicated team of highly competent specialists.

Jesper Mailind

CEO

The LEO Foundation’s CEO since 2017.

Jesper’s background includes executive management positions in:

Alectia A/S, President and CEO
RTX A/S, President and CEO
GN Resound A/S, President and CEO
GN Great Nordic A/S, EVP
Nycomed Pharma (now Takeda), SVP
McKinsey & Company, Associate

Jesper holds an MBA from Insead and a BSc in economics from Copenhagen Business School.

Other positions

Etac Group, Non-executive board member
Sonion, Non-executive board member
RTX A/S, Non-executive board member and Vice Chairman

+ 45 32 72 51 10
LinkedIn

Ida Brams

Chief Grant Officer

Ida is responsible for the LEO Foundation’s grants and awards and for the Foundation’s grant strategy.

Ida’s background includes both R&D, project management and strategy work at LEO Pharma. Before joining LEO Pharma, Ida worked at the Carlsberg Laboratory.

Ida holds an MSc in chemical engineering and a PhD in organic chemistry, both from the Technical University of Denmark.

Joined the Foundation in 2017.

+45 25 66 40 67
ida.brams@leo-foundation.org
LinkedIn

Morten Stampe Christensen

Chief Investment Officer

Morten is responsible for the LEO Foundation’s financial assets and investment strategy. The Foundation’s financial assets are all held in the wholly owned subsidiary, LEO Holding A/S.

Morten has previously worked at Danske Bank and BG Bank with a large array of finance and investment-related tasks, e.g.:

Investment strategies
Asset allocation
Hedge funds
Alternative investments
Risk management

Morten holds a PhD in economics from Aarhus University and an MSc in economics from Aarhus University and University of Southampton.

Joined the Foundation in 2017.

morten.stampe@leo-foundation.org
LinkedIn

Lars Kruse

Scientific Officer

Lars is responsible for coordinating the Foundation’s grants and handles scientific and administrative matters relating to the Foundation’s donations. He also works on further developing the philanthropic area.

Lars has a scientific background having worked in academic research for 16 years on projects ranging from molecular mechanisms in migraine over COPD to sleep disorders and osteoporosis.

Lars holds an MSc in human biology and a PhD in neuroscience, both from University of Copenhagen.

Joined the Foundation in 2017.

+45 30 46 42 91
lars.kruse@leo-foundation.org
LinkedIn

Lars Thørs

Senior Investment Director

Lars is responsible for is co-managing the Financial Portfolio of the LEO Foundation. Lars’ tasks include:

Asset allocation
Investment strategy
Manager selection
Alternative investments
Risk management

Lars has a broad background from the financial world in general and from investment strategy, risk assets and risk management in particular. He has previously worked at Danske Capital, Danica Pension and PFA.

Lars holds a Graduate Diploma in Business Administration majoring in both Finance and International Management & Economics from Copenhagen Business School.

Joined the Foundation in 2018.

lars.thoers@leo-foundation.org
LinkedIn

Mette Poulsen

Finance Manager

Mette is responsible for financial planning, budgeting, controlling and reporting, including:

Annual reports
Budgets
Budgetary control
Financial reporting

Mette has a background as finance manager and business process consultant in Denmark and abroad and has among others worked at Ferring Pharmaceuticals and Danisco (Dupont).

Mette holds a Graduate Diploma in Business Administration from Copenhagen Business School and an MSc in biology from University of Copenhagen.

Joined the Foundation in 2017.

+45 31 53 40 49
mette.poulsen@leo-foundation.org
LinkedIn

Pernille Mørch-Sørensen

Management Assistant

Pernille is responsible for handling various administrative tasks across the organisation including support to CEO Jesper Mailind.

Pernille has previously worked as Executive Secretary at Dampskibsselskabet NORDEN A/S.

Pernille holds an MA in Business Language and International Business Communication – Translator and Interpreter, English from Copenhagen Business School.

Joined the Foundation in 2020.

+ 45 20 86 17 84
pernille.moerch@leo-foundation.org
LinkedIn

Peter Kjeldsen Hansen

Director, Legal and Business Development

Peter is responsible for handling the Foundation’s legal matters and acts as corporate secretary to the Board of Trustees. Furthermore, he supports the on-going work in developing corporate strategies and forming new partnerships and collaborations. 

Peter has previously worked as attorney-at-law at LEO Pharma and Horten Law Firm. 

Peter holds an MA in Law from University of Copenhagen and is admitted to the bar. 

Joined the Foundation in 2017. 

+45 25 14 14 14
peter.kjeldsen@leo-foundation.org
LinkedIn 

Signe Krabek

Head of Communication and Public Affairs

Signe is responsible for the LEO Foundation’s communication activities, including internal and external communication, stakeholder relations and public affairs.

Signe has a background within communication from the Velux Foundations, the Think Tank DEA and as external lecturer at the Copenhagen Business School.

Signe is MSocSC in Political Communication and Management from Copenhagen Business School and holds a BSc from Roskilde University.

Joined the Foundation in 2020.

+ 45 20 49 68 69
signe.krabek@leo-foundation.org
LinkedIn

Victoria Sværke Rasmussen

Student Assistant

LEO Historial Archives and Museum

In a former porter home at LEO Pharma in Ballerup, Denmark, you will find “LEO Historical Archives and Museum”, which is run by the LEO Foundation.  A museum, an archive and a collection that tell the story of LEO Pharma.

Sophie Seebach

Head of LEO Historical Archives and Museum

Sophie is head of LEO Historical Archives and Museum. A museum, an archive and a collection that tell a story of the pharmaceutical company LEO Pharma.

Sophie has a background from Moesgaard Museum where she was a curator and was responsible for the museum’s ethnographic collection. At Moesgaard Museum, she also managed the blog ethnographica.net.

Sophie holds a master’s degree and a PhD in Anthropology – both from Aarhus University.

Joined the Foundation in 2020.

+45 31 12 94 32
sosee@leo-pharma.com
LinkedIn

Arne Mandøe

Senior Historian, LEO Historical Archives and Museum

Arne is responsible for curating the rich LEO history through careful tending to the LEO Historical Archives and Museum.

Arne has a background from LEO Pharma A/S and the University Library of Copenhagen.

Arne holds an BSc in Scandinavian Language and Literature from University of Aarhus and an MA in Library and Information Science from the Royal School of Library and Information Science.

Joined the Foundation in 2016.

+ 45 32 72 51 10
amadk@leo-pharma.com
LinkedIn

Skin tissue samples from 3,000 patients to give new insights into psoriasis and eczema

Read article

DKK 15 million to five excellent skin research projects

Read article